Endpoints News ٢ ديسمبر ٢٠٢٥ ARCH, Parker Institute build next big oncology bet with suite of programs and startup acquisition
Endpoints News ٢ ديسمبر ٢٠٢٥ Pfizer culls ulcerative colitis candidate; Tiziana to try spinning out IL-6 drug
Endpoints News ٢ ديسمبر ٢٠٢٥ As approval date looms, Cytokinetics gears up for David-and-Goliath battle with Bristol Myers
Endpoints News ٢ ديسمبر ٢٠٢٥ Imvax shares Phase 2b data for glioblastoma treatment, plans to meet with FDA
Endpoints News ٢ ديسمبر ٢٠٢٥ House passes bill to reauthorize rare pediatric PRV program; Senate next
Endpoints News ١ ديسمبر ٢٠٢٥ Janux’s prostate cancer immunotherapy’s response rate drops, according to new early-stage data
Endpoints News ١ ديسمبر ٢٠٢٥ Belite Bio aims for first approval of Stargardt disease treatment with Phase 3 success